Literature DB >> 15199039

Using pharmacogenetics to improve drug safety and efficacy.

Susanne B Haga1, Wylie Burke.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15199039     DOI: 10.1001/jama.291.23.2869

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Investigation of IVS14 + 1G > A polymorphism of DPYD gene in a group of Bosnian patients treated with 5-Fluorouracil and capecitabine.

Authors:  Timur Cerić; Nermina Obralić; Lejla Kapur-Pojskić; Drazenka Macić; Semir Beslija; Anes Pasić; Sejla Cerić
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  Pharmacogenetic study of statin therapy in cholesterol reduction.

Authors:  Theodore A Kotchen
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

3.  Principles for evidence-based drug formulary policy.

Authors:  Gregory E Simon; Bruce M Psaty; Jennifer Berg Hrachovec; Marc Mora
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

4.  Randomised by (your) god: robust inference from an observational study design.

Authors:  George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

Review 5.  Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors:  Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal:  Curr Opin Mol Ther       Date:  2008-06

Review 6.  Decoding the biology of language and its implications in language acquisition.

Authors:  D R Rahul; R Joseph Ponniah
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 7.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?

Authors:  Aurea Lima; Miguel Bernardes; Rita Azevedo; Rui Medeiros; Vítor Seabra
Journal:  Int J Mol Sci       Date:  2015-06-16       Impact factor: 5.923

9.  FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.

Authors:  Giulia Paroni; Davide Seripa; Andrea Fontana; Grazia D'Onofrio; Carolina Gravina; Maria Urbano; Leandro Cascavilla; Fabio Pellegrini; Antonio Greco; Alberto Pilotto
Journal:  Clin Interv Aging       Date:  2014-10-21       Impact factor: 4.458

10.  Students' knowledge and views on pharmacogenomic education in the medical curriculum.

Authors:  Manju Agrawal; Lopamudra Kirtania; Anuja Jha; Rajesh Hishikar
Journal:  Indian J Pharmacol       Date:  2021 Jan-Feb       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.